HER2- positive breast cancer /
Sara Hurvitz, MD, Division of Hematology/Oncology, david Geffen School of Medicine, University of California, Los Angeles; Kelly Mccann, MD, PHD, Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles.
- St. Louis, Missouri : Elsevier, c2019
- xvi, 247 pages : illustrations.